A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Clinical trial NCT03144804 · COMPLETED
Trial details
- NCT number
- NCT03144804
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2020-03-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.